ShadowBuys

Lobbying disclosures · Lobbying report

AMGN: third_quarter 2026 lobbying report

issues related to pharmaceutical drugs

Follow AMGN
Became public
Oct 18, 2026, 6:10 PM EDT
Event / period date
Not stated
Collected
Nov 8, 2026, 11:40 AM EST

Why this is connected

Exact legal-name match: AMGEN INC (https://www.sec.gov/Archives/edgar/data/318154/).

Reported lobbying amounts

Income: $7,500.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/871c0857-4aeb-42e9-b59c-5a6554e204f7/","filing_uuid":"871c0857-4aeb-42e9-b59c-5a6554e204f7","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/871c0857-4aeb-42e9-b59c-5a6554e204f7/print/","filing_document_content_type":"text/html","income":"7500.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeffrey J. Kimbell","dt_posted":"2026-10-18T18:10:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th Street NW","registrant_address_2":"Suite 920","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":46038,"url":"https://lda.gov/api/v1/registrants/46038/","house_registrant_id":34381,"name":"JEFFREY J. KIMBELL & ASSOCIATES, INC.","description":"Consulting Firm","address_1":"401 9th Street NW","address_2":"Suite 920","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY KIMBELL","contact_telephone":"+1 202-735-2590","dt_updated":"2026-10-19T16:46:08.608430-04:00"},"client":{"id":58793,"url":"https://lda.gov/api/v1/clients/58793/","client_id":58793,"name":"AMGEN INC.","general_description":"pharmaceutical","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-02-07"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"issues related to pharmaceutical drugs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42442,"prefix":"mr","prefix_display":"MR.","first_name":"JEFFREY","nickname":null,"middle_name":"J","last_name":"KIMBELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53650,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"HERZOG","suffix":null,"suffix_display":null},"covered_position":"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President","new":false},{"lobbyist":{"id":60159,"prefix":null,"prefix_display":null,"first_name":"KEITH","nickname":null,"middle_name":null,"last_name":"STUDDARD","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Marsha Blackburn","new":false},{"lobbyist":{"id":139878,"prefix":"mr","prefix_display":"MR.","first_name":"KENNETH","nickname":null,"middle_name":"LEE","last_name":"HODGE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67296,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"R","last_name":"RAY","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Rep. Mike Kelly","new":false},{"lobbyist":{"id":68519,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"RUDLOFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149308,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"KEMPER","suffix":null,"suffix_display":null},"covered_position":"Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services","new":false},{"lobbyist":{"id":150293,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"MEEKS","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander","new":false},{"lobbyist":{"id":153987,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"FRITSCH","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce","new":false},{"lobbyist":{"id":155140,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"PEREZ","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":true},{"lobbyist":{"id":155141,"prefix":null,"prefix_display":null,"first_name":"COOPER","nickname":null,"middle_name":null,"last_name":"CHAMBLEE","suffix":null,"suffix_display":null},"covered_position":"Intern, Sen. Tim Scott","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in AMGN

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.